Evaluation of proliferative activity of brain tumors using Ki-67 LI*AgNORs

被引：0
|
作者：
Nakabayashi, H
Sunada, I
Hakuba, A
机构：
来源：
11TH INTERNATIONAL CONGRESS OF NEUROLOGICAL SURGERY, VOLS 1 AND 2 | 1997年
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
Ki-67 LI*AgNORs was evaluated in 92 brain tumors. The mean scores of Ki-67 LI*AgNORs were as follows: glioblastoma 59.4; anaplastic astrocytoma 22.4; low grade astrocytoma 4.60; recurrent meningioma 7.87; non-recurrent meningioma 1.52; pituitary adenoma 1.85; acoustic neurinoma 1.47. A statistically significant differrence in Ki-67 LI*AgNORs was observed between glioblastomas, high grade gliomas and low grade gliomas (p<0.005). A statistically significant differrence in Ki-67 LI*AgNORs was observed between recurrent meningiomas and non-recurrent meningiomas (p<0.005). In meningiomas, Ki-67 LI*AgNORs was a useful parameter for discriminating between recurrent and non-recurrent group. Ki-67 LI*AgNORs may serve as a useful prognostic indicator in brain tumors.
引用
收藏
页码：609 / 611
页数：3
相关论文
共 50 条
  • [31] Investigation of The Effect of Radiotherapy on The Proliferative Index (Ki-67) in Recurring Diffuse Glial Tumors
    Midi, Ahmet
    Belirgen, Muhittin
    Caglar, Hale
    Sav, Aydin
    [J]. JOURNAL OF NEUROLOGICAL SCIENCES-TURKISH, 2011, 28 (01): : 65 - 70
  • [32] KI-67 PROLIFERATIVE INDEX CHANGES FOLLOWING RESECTION AND/OR RADIATION THERAPY IN INTRACRANIAL TUMORS
    Tormenti, Matthew Justin
    Faraji, Amir
    Flickinger, John
    Engh, Johnathan A.
    [J]. NEURO-ONCOLOGY, 2009, 11 (05) : 647 - 647
  • [33] Prognostic value of the proliferative index determined by Ki-67 immunostaining in superficial bladder tumors
    Pfister, C
    Lacombe, L
    Vezina, MC
    Moore, L
    Larue, H
    Têtu, B
    Meyer, F
    Fradet, Y
    [J]. HUMAN PATHOLOGY, 1999, 30 (11) : 1350 - 1355
  • [34] Correlation of Ki-67 Proliferative Index with Pathological Features and Outcome in Pancreatic Endocrine Tumors
    Zerbi, A.
    Falconi, M.
    Rindi, G.
    Fave, Delle G.
    Tomassetti, P.
    Pasquali, C.
    Capitanio, V
    Boninsegna, L.
    Di Carlo, V
    [J]. NEUROENDOCRINOLOGY, 2010, 92 (01) : 68 - 68
  • [35] Characterization of brain tumors by MRS, DWI and Ki-67 labeling index
    Calvar, JA
    Meli, FJ
    Romero, C
    Yánez, ML
    Martinez, AR
    Lambre, H
    Taratuto, AL
    Sevlever, G
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2005, 72 (03) : 273 - 280
  • [36] Characterization of brain tumors by MRS, DWI and Ki-67 labeling index
    J. A. Calvar
    F. J. Meli
    C. Romero
    M. L. Calcagno P. Yánez
    A. R. Martinez
    H. Lambre
    A. L. Taratuto
    G. Sevlever
    [J]. Journal of Neuro-Oncology, 2005, 72 : 273 - 280
  • [37] MONOCLONAL-ANTIBODY KI-67 AS A MARKER OF PROLIFERATIVE ACTIVITY IN MONOCLONAL GAMMOPATHIES
    GIRINO, M
    RICCARDI, A
    LUONI, R
    UCCI, G
    CUOMO, A
    [J]. ACTA HAEMATOLOGICA, 1991, 85 (01) : 26 - 30
  • [38] ESTIMATING THE PROLIFERATIVE ACTIVITY IN BREAST-CANCER - IS KI-67 IMMUNOSTAINING NECESSARY
    YOUNES, M
    MODY, DR
    MILLER, CC
    LECHAGO, LV
    LAUCIRICA, R
    [J]. LABORATORY INVESTIGATION, 1995, 72 (01) : A28 - A28
  • [39] Proliferative activity (Ki-67) and level of VEGF gene expression in gemistocytic astrocytomas
    Matsko, D. E.
    Matsko, M. V.
    Ulitin, A. Y.
    Zrelov, A. A.
    Iyevleva, A. G.
    Skliar, S. S.
    Shelekhova, K.
    Imyanitov, E. N.
    [J]. VIRCHOWS ARCHIV, 2017, 471 : S221 - S221
  • [40] Impact of the proliferative index Ki-67 on response to PRRT
    Ezziddin, S.
    Opitz, M.
    Ahmadzadehfar, H.
    Attassi, M.
    Biermann, K.
    Guhlke, S.
    Willinek, W.
    Sabet, A.
    Wardelmann, E.
    Biersack, H.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S231 - S231
12345